Search for Herbal Teas Recipes by Symptom:

Hou Liufa

Disclaimer: These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. All references in this article to TCM syndrome differentiation, herbal medicines, teas, and decoctions are intended to promote TCM culture and are provided solely for educational and reference purposes.

Hou Liufa

Expert: Hou Liufa

侯留法
Chief Physician of TCM, Master of Medicine.Deputy Director of the Digestive Ward of its Affiliated Hospital.
Specialties:He specializes in the integrated treatment with Chinese and Western medicine for fatty liver, viral hepatitis, liver cirrhosis, liver cancer, gastrointestinal disorders and digestive tract tumors. During the immune tolerance phase, he applies the therapy of *unblocking Yang and detoxification* to facilitate viral seroconversion. In the immune clearance phase, he adopts sequential therapy and immune regulation to stabilize the condition. For liver cirrhosis, the methods of activating blood circulation to dissipate stasis, softening the liver and resolving hard masses are used to reverse disease progression. He has long been engaged in clinical and experimental research on digestive diseases with integrated Chinese and Western medicine.
References: He has published more than 20 academic papers, authored 7 monographs, and obtained 6 research achievements.

• Profile Summary

Hou Liufa, Chief Physician of TCM, Master of Medicine. He currently serves as Director of the Digestive Research Laboratory at Henan Academy of Chinese Medicine, and Deputy Director of the Digestive Ward of its Affiliated Hospital. He specializes in the integrated treatment with Chinese and Western medicine for fatty liver, viral hepatitis, liver cirrhosis, liver cancer, gastrointestinal disorders and digestive tract tumors. During the immune tolerance phase, he applies the therapy of unblocking Yang and detoxification to facilitate viral seroconversion. In the immune clearance phase, he adopts sequential therapy and immune regulation to stabilize the condition. For liver cirrhosis, the methods of activating blood circulation to dissipate stasis, softening the liver and resolving hard masses are used to reverse disease progression. He has long been engaged in clinical and experimental research on digestive diseases with integrated Chinese and Western medicine.

• Academic & Social Positions

Chairman, Henan Provincial Professional Committee of TCM Hepatobiliary Diseases Council Member, Hepatology Committee of World Federation of Chinese Medicine Societies (WFCMS) Committee Member, 6th Hepatology Committee of Chinese Society of Integrated Traditional and Western Medicine Editorial Board Member, Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases Committee Member, Henan Provincial Hepatology Committee

• Research Achievements

He has published more than 20 academic papers, authored 7 monographs, and obtained 6 research achievements.